Literature DB >> 26675808

Perspectives on zebrafish neurobehavioral pharmacology.

Edward D Levin1, Allan V Kalueff2, Robert T Gerlai3.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26675808     DOI: 10.1016/j.pbb.2015.11.007

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


× No keyword cloud information.
  4 in total

1.  Developmental Exposure to Low Concentrations of Organophosphate Flame Retardants Causes Life-Long Behavioral Alterations in Zebrafish.

Authors:  Lilah Glazer; Andrew B Hawkey; Corinne N Wells; Meghan Drastal; Kathryn-Ann Odamah; Mamta Behl; Edward D Levin
Journal:  Toxicol Sci       Date:  2018-10-01       Impact factor: 4.849

2.  The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder.

Authors:  Gabriel D Bosse; Roberto Cadeddu; Gabriele Floris; Ryan D Farero; Eva Vigato; Suhjung J Lee; Tejia Zhang; Nilesh W Gaikwad; Kristen A Keefe; Paul Em Phillips; Marco Bortolato; Randall T Peterson
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

3.  Changes in Brain Monoamines Underlie Behavioural Disruptions after Zebrafish Diet Exposure to Polycyclic Aromatic Hydrocarbons Environmental Mixtures.

Authors:  Caroline Vignet; Verena M Trenkel; Annick Vouillarmet; Giampiero Bricca; Marie-Laure Bégout; Xavier Cousin
Journal:  Int J Mol Sci       Date:  2017-03-04       Impact factor: 5.923

4.  Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM).

Authors:  Shuhui Zhang; Xiaodong Liu; Mingzhu Sun; Qiuping Zhang; Teng Li; Xiang Li; Jia Xu; Xin Zhao; Dongyan Chen; Xizeng Feng
Journal:  Behav Brain Funct       Date:  2018-06-14       Impact factor: 3.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.